| Prev Close | 72.74 |
| Day Low/High | 72.03 / 73.42 |
| 52 Wk Low/High | 42.62 / 81.91 |
| Avg Volume | 1.09M |
| Exchange | NASDAQ |
| Shares Outstanding | 87.00M |
| Market Cap | 6.33B |
| EPS | -0.60 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Jim Cramer says if you can't handle the newsflow, both real and fake, you may need to use this rally to lighten up. But if you can, then hold on, stick around and make money.
DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) is pleased to announce that the U.
The US Patent Office Patent Trial and Appeal Board recently ruled to uphold the validity of WaveForm Technologies Inc. patents in the emerging field of continuous glucose monitoring
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2017.
Jim discusses Comcast's bid for Sky, Broadcom, Fed Chair Powell's testimony and more.
Fitbit shares dropped 13% in after-hours trading on Monday after the company missed on earnings and revenue for its fiscal fourth quarter.
Fitbit shares fell about 12% after hours on Monday after missing on both the top and bottom lines.
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Steven Pacelli, Executive Vice President, Strategy and Corporate...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2017 financial results after market close on Tuesday, February 27, 2018.
UnitedHealthcare, the market leader in Medicare benefit plans 1, and DexCom, Inc.
DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring ("CGM"), today reported that it achieved preliminary, unaudited revenue of approximately $218 million for the fourth quarter ended December 31, 2017,...
Callout: Fed raises interest rates, stocks grind higher
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President and Chief Executive Officer, will present an...
TheStreet recounts the successes and failures of the biggest names in the activism game.
Stocks finish higher in an up and down week.
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Quentin Blackford, Executive Vice President, Chief Financial Officer;...
Oil hits highest level since 2015 in holiday-shortened week. We drop a name from the portfolio.
Companies aim to improve disease management.
DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, today announced a development agreement with Eli Lilly and Company (NYSE: LLY) to include Dexcom CGM into Lilly's...
A rebound late in the week helps the markets recover from a bout of selling. We add a name to the portfolio.
Jim Cramer says don't be too quick to ascribe today's gains just to tax reform. This rally was roaring well before that. Instead, credit Cisco and Wal-Mart Stores.
Quarterly filings provide a window into new allocations made by insurgent fund managers Paul Singer, Glenn Welling, Barry Rosenstein and Keith Meister. Could M&A campaigns be next?
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate...
In honor of National Diabetes Awareness Month, DexCom, Inc. (Nasdaq: DXCM) has launched the "Call of the Warrior" campaign on social media to support those living with diabetes, a chronic disease that affects more than...
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2017.
Markets ride a tide of earnings. In the portfolio, we trimmed 3 positions.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GSK, OPB, RES, SIX, TUP Downgrades: AXS, BPL, DXCM, KRA, OI, TRK, WMS Initiations: NTB Read on to get TheStreet Quant Ratings' detailed report:
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President and Chief Executive Officer, will present an...
